Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000565
UniProt IDQ8IZL9
Primary gene name(s)CDK20
Synonym gene name(s)CCRK, CDCH
Protein nameCyclin-dependent kinase 20
Protein functionRequired for high-level Shh responses in the developing neural tube. Together with TBC1D32, controls the structure of the primary cilium by coordinating assembly of the ciliary membrane and axoneme, allowing GLI2 to be properly activated in response to SHH signaling, By similarity. Involved in cell growth. Activates CDK2, a kinase involved in the control of the cell cycle, by phosphorylating residue 'Thr-160'. {ECO:0000250, ECO:0000269|PubMed:14597612}.
Subcellular locationNucleus {ECO:0000269|PubMed:14597612}. Cytoplasm {ECO:0000250}. Cell projection, cilium {ECO:0000250}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q8IZL9
Gene Ontology
(Biological Process)
Complete annatation
cell cycle [GO:0007049];
cell division [GO:0051301];
multicellular organism development [GO:0007275]
Gene Ontology
(Molecular Function)
Complete annatation
ATP binding [GO:0005524];
cyclin-dependent protein serine/threonine kinase activity [GO:0004693]
Gene Ontology
(Cellular Component)
Complete annatation
cilium [GO:0005929];
cytoplasm [GO:0005737];
nucleus [GO:0005634]
Protein-protein interaction117096
Phylogenetic treeQ8IZL9
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-0.6929168061449380.05169488338199220.102600116188226
AZA vs. DISU-0.1905571118116080.4960662948198960.934705997400936
AZA vs. IL7-0.1117858767455060.6241285623741260.999311006273513
AZA vs. SAHA-0.6990065444587070.1339321279552590.466364725524965
DISU vs. CD30.4906707846277480.2048916678930550.324664879829698
DISU vs. IL70.06689610484620140.8098403700896360.959296632507683
DISU vs. SAHA-0.5080070681886280.2783862606593320.658643537581914
DMSO vs. AZA0.08675379036840970.6742843608472361
DMSO vs. CD30.7659690515327040.02656010564270960.0567235598961469
DMSO vs. DISU0.2748341020920070.3066165011672540.812005271058955
DMSO vs. IL7-0.1897836745800780.373563552313460.831458117840584
DMSO vs. SAHA-0.7917413133250310.09192816393484660.355152360590124
HIV vs. Mock in Activation-0.2404396342192940.7239231701210940.999983755607037
HIV vs. Mock in Latency-0.0463491401657460.8289215699170790.999834320637052
IL7 vs. CD30.5816804086762140.09609967988012090.183914483853868
SAHA vs. CD3-0.03197857072694450.9552673787799930.970272398429947
SAHA vs. IL7-0.5888196574983160.2513740474295580.494739834306458
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) TRUE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.276616 0.345013
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found
Menu